The CHOICE Institute is pleased to announce the 2024-26 cohort of HEOR Fellows who will start their programs on July 1, 2024. Our HEOR fellows work closely with faculty in the CHOICE Institute on projects where they learn first-hand how to apply the principles of outcomes research to real-life problems. These fellowships provide students with a year of study at the University of Washington, usually combined with a period of applied research at the sponsoring company. The year of study leads to an MS degree in Health Economics & Outcomes Research.
These training programs in health economics, outcomes research, and policy each combine the resources of a leading academic center for pharmaceutical economics and policy with the dynamic, real-world training of major pharmaceutical and biotechnology companies recognized for their commitment to innovation. Read more about our industry fellowship programs.
This year, we are excited to be welcoming our largest cohort of fellows to date– with the launch of our two new industry partnerships, with Novo Nordisk and Sanofi.
Meet the fellows:
AbbVie
Rachel Kneitel, St. John’s University
Olivia Yip, University of California San Diego
Bayer
Jean Lee, University of Illinois at Chicago
Genentech
Nissen Weisman, University of Connecticut
Divya Jain, University of Colorado Denver
Novo Nordisk
Minseon Chung, University at Buffalo
Sanofi
Kevin Li, University of Washington
Seagen
Kathryn Perkins, University of Southern California